Dario Akaberi
Postdoctoral position at Department of Medical Biochemistry and Microbiology; Infection and Immunity; Åke Lundkvist
- E-mail:
- dario.akaberi@imbim.uu.se
- Visiting address:
- BMC
Husargatan 3
752 37 UPPSALA - Postal address:
- Box 582
751 23 UPPSALA
Publications
Recent publications
Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024
- DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
- Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
Part of Parasites & Vectors, 2024
- DOI for Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
- Download full text (pdf) of Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
Part of Scientific Reports, 2024
- DOI for Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
- Download full text (pdf) of Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
Identification of protease inhibitors against Flaviviruses and Coronaviruses
2023
Part of Viruses, 2023
- DOI for Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
- Download full text (pdf) of Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
All publications
Articles in journal
Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024
- DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
- Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
Part of Parasites & Vectors, 2024
- DOI for Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
- Download full text (pdf) of Vector competence of Swedish Culex pipiens mosquitos for Japanese encephalitis virus
Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
Part of Scientific Reports, 2024
- DOI for Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
- Download full text (pdf) of Study on the temporal and spatial distribution of Culex mosquitoes in Hanoi, Vietnam
Part of Viruses, 2023
- DOI for Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
- Download full text (pdf) of Reduced Binding between Omicron B.1.1.529 and the Human ACE2 Receptor in a Surrogate Virus Neutralization Test for SARS-CoV-2
Part of Journal of the American Chemical Society, p. 2905-2920, 2022
- DOI for Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
- Download full text (pdf) of Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Presymptomatic viral shedding and infective ability of SARS-CoV-2: a case report
Part of Heliyon, 2021
- DOI for Presymptomatic viral shedding and infective ability of SARS-CoV-2: a case report
- Download full text (pdf) of Presymptomatic viral shedding and infective ability of SARS-CoV-2: a case report
Part of Antiviral Research, 2021
SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
Part of Virology Journal, 2021
- DOI for SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
- Download full text (pdf) of SARS-CoV-2 in hospital indoor environments is predominantly non-infectious
Part of Infection Ecology & Epidemiology, 2020
- DOI for Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for 4 assessment of past exposure to SARS-CoV-2
- Download full text 1 (pdf) of Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for 4 assessment of past exposure to SARS-CoV-2
- Download full text 2 (pdf) of Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for 4 assessment of past exposure to SARS-CoV-2
Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
Part of Redox Biology, 2020
- DOI for Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
- Download full text (pdf) of Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
Part of Journal of Biomolecular Structure and Dynamics, p. 5526-5536, 2020
- DOI for Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
- Download full text (pdf) of Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
Part of Scientific Reports, 2020
- DOI for Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
- Download full text (pdf) of Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards
Part of Scandinavian Journal of Gastroenterology, p. 1042-1050, 2019
- DOI for Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway
- Download full text (pdf) of Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway
Part of Pathogens and Global Health, p. 210-226, 2018
Part of Molecular Phylogenetics and Evolution, p. 58-63, 2018
Part of Antiviral Therapy, p. 485-493, 2018
Part of Scandinavian Journal of Gastroenterology, p. 1347-1353, 2018
- DOI for Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.
- Download full text (pdf) of Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.